A) INNO
- Innovative concepts and ideas for biobanking |
|
A1 :
Pitch your innovation concept/idea |
A2 :
Practical issues - ask the experts |
A3 :
Biobanking for beginners |
A4 : Business planning |
A5
: Biobanking in the spotlight – International standards and future perspectives |
A6 :
Biobanking for experts |
A7 :
Biobanking governance |
A8 :
Biobanking in the Spotlight - International partnerships |
A9 : Biobanking to preserve
the biodiversity of species |
A10 :
Biobanking meets regulatory |
|
B) PATIENTS - Putting patients
into the center of the health innovation process |
|
B1 :
Participation of patients and public in biobanking |
B2 :
ELSI issues - practical |
B3 :
Patients to learn from: bridging between science and healthcare |
B4 :
From donors to biobanking - from biobanks to patients |
B5 :
Ethics cafe: "sharing results with donors" |
B6 : New
concepts and tools for public engagement |
B7
: Biobanking and industry |
B8 :
What will change under the upcoming GDPR? |
|
C) DATA - Data in biobanking -
An emerging new era for data management |
|
C1 :
Medical imaging and biobanking (radiology and digital pathology) |
C2 : How
to implement data protection - IT tools |
C3 :
Biobanks as data and knowledge infrastructures |
C4 :
Multi-omics data integration / visualization |
C5 :
Integration of routine clinical data into research/biobanks |
|
D) BIOMARKERS - Building
bridges through biomarkers |
|
D1 :
Biobanks for biomarker validation |
D2 :
Biobanks and personalized medicine: clinical trials and innovation |
D3 :
Companion diagnostics: how can biobanks support their development? |
D4 :
Networking across European medical societies for enhancing translational
medicine (workshop) |
D5 : Precision medicine and quality issues |
|
E) QM - Quality management |
|
E1 : Improved output quality of human
biological material across European biobanks |
E2 : Sample integrity and quality assured
biobanking |
E3 : QMS, a tool to improve performance |
|
F) BBMRI-LPC Forum Meeting (September 15-16)
|
F1 :
Infrastructure policies in widening countries? |
F2 : How
BBMRI-ERIC can support emerging biobanks? |
F3
: a) Use of EU structural funds for
establishment of biobanks
b) New support mechanisms for biobanks in widening countries |
F4 :
Infrastructure policies in widening countries? |
|
G) Biobanking for environmental and biodiversity research
|
G1 :
Environmental specimen banks |
G2 :
Global Genome Biodiversity Network (GGBN) |